Variant report
Variant | esv1819896 |
---|---|
Chromosome Location | chr21:46817380-46821907 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:44)
- CpG islands (count:0)
- Chromatin interactive region (count:17)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:44 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr21:46818852-46818853 | K562 | blood: | n/a | n/a |
2 | BACH1 | chr21:46820940-46821280 | K562 | blood: | n/a | n/a |
3 | BACH1 | chr21:46820955-46821287 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | CBX3 | chr21:46820914-46821705 | K562 | blood: | n/a | n/a |
5 | CBX3 | chr21:46821033-46821469 | HCT-116 | colon: | n/a | n/a |
6 | CBX3 | chr21:46820985-46821465 | K562 | blood: | n/a | n/a |
7 | CEBPB | chr21:46820833-46821043 | HepG2 | liver: | n/a | chr21:46820993-46821004 |
8 | CEBPB | chr21:46820897-46821028 | Hela-S3 | cervix: | n/a | chr21:46820993-46821004 |
9 | ELF1 | chr21:46820976-46821260 | K562 | blood: | n/a | n/a |
10 | EP300 | chr21:46821044-46821270 | K562 | blood: | n/a | n/a |
11 | FOS | chr21:46820892-46821075 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | GATA1 | chr21:46821616-46822295 | PBDE | blood: | n/a | n/a |
13 | IRF1 | chr21:46821019-46821257 | K562 | blood: | n/a | n/a |
14 | JUND | chr21:46821010-46821280 | K562 | blood: | n/a | n/a |
15 | KAP1 | chr21:46820972-46821580 | HEK293 | kidney: | n/a | n/a |
16 | KAP1 | chr21:46820993-46821500 | U2OS | brain: | n/a | n/a |
17 | KAP1 | chr21:46820622-46822336 | K562 | blood: | n/a | n/a |
18 | MAFF | chr21:46820506-46821290 | HepG2 | liver: | n/a | chr21:46821058-46821076 |
19 | MAFF | chr21:46820530-46821342 | K562 | blood: | n/a | chr21:46821058-46821076 |
20 | MAFK | chr21:46820468-46821304 | HepG2 | liver: | n/a | chr21:46821060-46821070 chr21:46821059-46821074 chr21:46821061-46821070 |
21 | MAFK | chr21:46820897-46821264 | Hela-S3 | cervix: | n/a | chr21:46821060-46821070 chr21:46821059-46821074 chr21:46821061-46821070 |
22 | MAFK | chr21:46820848-46821272 | H1-hESC | embryonic stem cell: | n/a | chr21:46821060-46821070 chr21:46821059-46821074 chr21:46821061-46821070 |
23 | MAFK | chr21:46820474-46821258 | HepG2 | liver: | n/a | chr21:46821060-46821070 chr21:46821059-46821074 chr21:46821061-46821070 |
24 | MAFK | chr21:46820520-46821268 | IMR90 | lung: | n/a | chr21:46821060-46821070 chr21:46821059-46821074 chr21:46821061-46821070 |
25 | MAFK | chr21:46820887-46821303 | K562 | blood: | n/a | chr21:46821060-46821070 chr21:46821059-46821074 chr21:46821061-46821070 |
26 | MAX | chr21:46820969-46821260 | K562 | blood: | n/a | n/a |
27 | MAZ | chr21:46821082-46821259 | K562 | blood: | n/a | n/a |
28 | MYC | chr21:46821087-46821186 | K562 | blood: | n/a | n/a |
29 | MYC | chr21:46821055-46821250 | K562 | blood: | n/a | n/a |
30 | RCOR1 | chr21:46821020-46821281 | K562 | blood: | n/a | n/a |
31 | SETDB1 | chr21:46820982-46821601 | U2OS | brain: | n/a | n/a |
32 | SETDB1 | chr21:46820980-46821666 | K562 | blood: | n/a | n/a |
33 | STAT3 | chr21:46821126-46821407 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | TCF12 | chr21:46821001-46821423 | A549 | lung: | n/a | n/a |
35 | TRIM28 | chr21:46820915-46821470 | K562 | blood: | n/a | n/a |
36 | TRIM28 | chr21:46820947-46821357 | K562 | blood: | n/a | n/a |
37 | USF1 | chr21:46820995-46821349 | K562 | blood: | n/a | n/a |
38 | USF1 | chr21:46821030-46821349 | A549 | lung: | n/a | n/a |
39 | USF1 | chr21:46821078-46821319 | SK-N-SH | brain: | n/a | n/a |
40 | ZMIZ1 | chr21:46821142-46821164 | K562 | blood: | n/a | n/a |
41 | ZNF143 | chr21:46820973-46821354 | K562 | blood: | n/a | n/a |
42 | ZNF143 | chr21:46820982-46821343 | H1-hESC | embryonic stem cell: | n/a | n/a |
43 | ZNF143 | chr21:46821116-46821213 | Hela-S3 | cervix: | n/a | n/a |
44 | ZNF384 | chr21:46820908-46821299 | K562 | blood: | n/a | n/a |
No data |
(count:17 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:46711273..46715306-chr21:46820522..46825546,4 | MCF-7 | breast: | |
2 | chr21:46737653..46759617-chr21:46790778..46832239,260 | MCF-7 | breast: | |
3 | chr21:46815716..46818136-chr21:46821509..46823991,2 | MCF-7 | breast: | |
4 | chr21:46815255..46817876-chr21:46826739..46829076,2 | MCF-7 | breast: | |
5 | chr21:46710906..46714348-chr21:46821217..46828800,8 | MCF-7 | breast: | |
6 | chr21:46818747..46822859-chr21:46823423..46827083,3 | K562 | blood: | |
7 | chr21:46821773..46824180-chr6:13571587..13574488,2 | MCF-7 | breast: | |
8 | chr21:46806345..46808330-chr21:46821258..46823797,2 | K562 | blood: | |
9 | chr21:46815514..46817659-chr21:46961656..46963644,2 | MCF-7 | breast: | |
10 | chr21:46821608..46828973-chr21:46832792..46845018,27 | MCF-7 | breast: | |
11 | chr21:46806273..46808920-chr21:46814989..46817504,2 | MCF-7 | breast: | |
12 | chr21:46817074..46822859-chr21:46823457..46827335,6 | K562 | blood: | |
13 | chr21:46815716..46818136-chr21:46821509..46823991,2 | MCF-7 | breast: | |
14 | chr21:46812731..46814919-chr21:46818975..46821230,3 | K562 | blood: | |
15 | chr21:46671592..46674476-chr21:46821725..46823483,2 | MCF-7 | breast: | |
16 | chr21:46808725..46810269-chr21:46819754..46821764,2 | MCF-7 | breast: | |
17 | chr21:46812352..46814348-chr21:46814629..46817990,4 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
COL18A1 | TF binding region |
ENSG00000183535 | chromatin interactions |
ENSG00000173638 | chromatin interactions |
ENSG00000229382 | chromatin interactions |
ENSG00000223768 | chromatin interactions |
ENSG00000182871 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4819095 | chr21:46817380-46817381 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs534685425 | chr21:46817381-46817382 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs553153107 | chr21:46817532-46817533 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs577904884 | chr21:46817550-46817551 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs139233338 | chr21:46817559-46817560 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs563342757 | chr21:46817592-46817593 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs575664024 | chr21:46817607-46817608 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs575459266 | chr21:46817624-46817625 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs544750387 | chr21:46817627-46817628 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs541859893 | chr21:46817655-46817656 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs562088955 | chr21:46817680-46817681 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs7283907 | chr21:46817698-46817699 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs562964229 | chr21:46817749-46817750 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs370986438 | chr21:46817761-46817762 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs7280258 | chr21:46817806-46817807 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs559380400 | chr21:46817814-46817815 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs76864899 | chr21:46817896-46817897 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs551922318 | chr21:46817961-46817962 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs149589855 | chr21:46817971-46817972 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs113622803 | chr21:46818019-46818020 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs71324422 | chr21:46818203-46818204 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs549439147 | chr21:46818212-46818213 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs76788060 | chr21:46818213-46818214 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs534648584 | chr21:46818226-46818227 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs560799018 | chr21:46818228-46818229 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs553016081 | chr21:46818277-46818278 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs577767869 | chr21:46818286-46818287 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs538378494 | chr21:46818311-46818312 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs182074780 | chr21:46818353-46818354 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs557101077 | chr21:46818370-46818371 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs185046808 | chr21:46818384-46818385 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs1980978 | chr21:46818397-46818398 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs551114576 | chr21:46818423-46818424 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs564961166 | chr21:46818434-46818435 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs560886351 | chr21:46818436-46818437 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs530531588 | chr21:46818509-46818510 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs2026884 | chr21:46818579-46818580 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs559342237 | chr21:46818667-46818668 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs536922157 | chr21:46818706-46818707 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs71334062 | chr21:46818707-46818708 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs567347811 | chr21:46818715-46818716 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs3083454 | chr21:46818719-46818720 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs533217821 | chr21:46818758-46818759 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs536083562 | chr21:46818775-46818776 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs190291992 | chr21:46818777-46818778 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs1041458 | chr21:46818782-46818783 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs531059266 | chr21:46818941-46818942 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs182463000 | chr21:46818942-46818943 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs188805495 | chr21:46818956-46818957 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs549642397 | chr21:46818975-46818976 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Mental retardation | 21031080 | CNVD |
Polymicrogyria | 21031080 | CNVD |
periventricular nodular heterotopia | 21031080 | CNVD |
Myelodysplastic syndrome | 21606161 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Autism | 18414403 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17899364 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 20473283 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 23341502 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 18632612 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Cholangiocarcinoma | 16830362 | CNVD |
Down syndrome | 17334655 | CNVD |
Neuroticism | 17667963 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Autoimmune polyendocrine syndrome | 18200029 | CNVD |
Prostate cancer | 19363497 | CNVD |
Lung cancer | 17086460 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Multiple myeloma | 16616336 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17142309 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Cancer | 20164919 | CNVD |
Lung cancer | 21203850 | CNVD |
Ependymoma | 20639864 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:46807800-46824400 | Weak transcription | Right Atrium | heart |
2 | chr21:46816200-46819600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr21:46816800-46818000 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr21:46818800-46819600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr21:46821000-46821800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
6 | chr21:46821800-46822600 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin01 | Skin |